Publication | Closed Access
Efficacy and safety of long‐term, continuous subcutaneous octreotide infusion for patients with different subtypes of K<sub>ATP</sub>‐channel hyperinsulinism
43
Citations
20
References
2012
Year
Long-term, continuous, subcutaneous octreotide infusion is a feasible alternative to surgery especially for patients with monoallelic KATP-channel mutations.
| Year | Citations | |
|---|---|---|
Page 1
Page 1